关于公司
- 法定名称: Bioworkshops
- 注册国家: China
- 地址: No. 5, Dongwang Road,, Suzhou Industrial Park, Suzhou
- 员工人数: 100 - 249
描述:
A full-service CDMO for antibody products, Bioworkshops offers development and cGMP manufacturing of drug substance and final product, including cell line development, process development, analytical methods, formulation, and process characterization/validation, with 13,000 liters of single-use cell culture capacity (200L to 2000L), three aseptic filling lines for vials, lyophilized products and prefilled syringes/cartridges up to 100,000 units per batch, along with product testing and CTD dossier support.
业务活动
生物制药产品
合同制造商(CMO)早期阶段公司（初创企业）
ATC(解剖学-治疗学-化学)分类系统
合同制造商(CMO)早期阶段公司（初创企业）
原研原料药
合同制造商(CMO)早期阶段公司（初创企业）
主要产品/服务
- 生物制药产品: Trastuzumab emtansine, Trastuzumab deruxtecan, Bedinvetmab, Benralizumab, Bevacizumab, Burosumab, Camrelizumab, Canakinumab, Casirivimab, Cetuximab, Cilgavimab, Daratumumab, Denosumab, Disitamab Vedotin, Dostarlimab, Dulaglutide, Dupilumab, Durvalumab, Eculizumab, Emicizumab, Erenumab, Etesevimab, Evolocumab, Faricimab, Fremanezumab, Frunevetmab, Galcanezumab, Guselkumab, Hyaluronidase Recombinant Human, Imdevimab, Lanadelumab, Lecanemab, Lokivetmab, Mepolizumab, Nirsevimab, Nivolumab, Ocrelizumab, Ofatumumab, Omalizumab, Palivizumab, Panitumumab, Pembrolizumab, Pertuzumab, Polatuzumab, Ramucirumab, Ranibizumab, Ravulizumab, Recombinant Zoster Vaccine, Risankizumab, Rituximab, Romiplostim, Romosozumab, Sarilumab, Sotatercept-csrk, Tezepelumab, Theralizumab, Tixagevimab & Cilgavimab, Tocilizumab, Trastuzumab, Ustekinumab, Adalimumab, Anifrolumab, Atezolizumab, Bamlanivimab, Bebtelovimab
- 生物制药服务: Cell Line Development, GMP manufacturing for cell culture products
- ATC(解剖学-治疗学-化学)分类系统: Respiratory Syncytial Virus Vaccine
我们的产品与服务
Sell · Biopharmaceutical Products
Certifications
Proofs
CPHI & PMEC China 2026
06/2026 – 06/2026
CPHI & PMEC China 2026
评分
(0)
(0)
(0)
(0)
(0)
评论
筛选：
排序方式：
暂无评论。
留下您的评分和评论